|
Dr
Lal Path Lab ties up with Raptakos
EHM
New Bureau - Mumbai
Delhi-based
Dr Lal Path Labs Pvt Limited (LPL) recently acquired Mumbai-based
Raptakos Brett Diagnostic Laboratories (RBDL) to foray
in Maharshtra.
Said
Dr Arvind lal, MD, LPL, "The acquisition of RBDL
marks the beginning of a new era in the history of laboratory
medicine in Mumbai where high quality, low cost diagnostic
tests shall be made available to the common man. This
acquisition comes as an entry point for LPL to cater its
highest quality lab services to the western part of the
country."
LPL
will bring its expertise to enhance the test menu of RBDL
with new path breaking tests. LPL plans to set up 25 collection
centres in Mumbai and another 25 in other cities of Maharashtra
and Gujarat. The lab collection centres will be backed
by LPL’s state of the art technology.
Through
this lab, LPL plans to offer for the first time in the
country, neonatal screening tests, obtained by heel puncture
dried blood spots on a filter paper thus making it possible
for paediatrics to send blood collected as dry spots thus
making it possible for paediatrcians to send blood collected
as dry spots on filter paper by ordinary post for screening
of diseases like congenital hypothyrpdism, phenyketonuruam
galactosemia, congenital adrenal hyperplasia, cystic fibrosis,
maple syrup urine disease, G6PD deficiency and haemoglobinopathies.
"For
the first time in western India, LPL will offer tests
like Atomic Absorption Spectrometry for heavy metal poisoning
and toxicity, LDL subfractions tests for coronary risk
assessment, latest hormonal tests including thyroid hormones
by the advanced ICMA technology," said Dr Lal adding,
"These tests would be offered at a very competitive
price." He announced that LPL plans to introduce
home-pick up service soon in Mumbai as a part of their
marketing initiatives. |
